BioSpace News Archive

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services to small-to-medium life science organizations around the world, announced their 20 th Anniversary kickoff celebrations this month, and is celebrating two decades of helping companies deliver clinical results across dozens of therapeutic areas.

Woebot Health, a pioneer in the development and delivery of fast acting digital therapeutics for mental health, announced that the Journal of Medical Internet Research (JMIR), a peer-reviewed medical journal covering eHealth, has published the results of its latest study.

Nexxt Spine, LLC a leading developer, manufacturer, and distributor of spinal solutions is proud to announce that the company has reached the milestone of over 11,000 NEXXT MATRIXX® 3D printed porous interbody products sold.

SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,975,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3.95 million.

Stuart Therapeutics, Inc. (“Stuart”), a clinical stage biopharmaceutical company conducting research and development of unique peptide therapeutics for ophthalmic diseases, today announced the completion of an $11 million Series A round of capital investment.

First challenge infection study in preclinical mouse model to provide evidence for protection against SARS-CoV-2 variant CVnCoV induces robust antibody titers with virus variant neutralizing capacity in immunized animals

Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and Inflammation.

Therap Services, the leading software solution for HIPAA-compliant electronic documentation for Home and Community-based Services (HCBS) and Long-Term Services and Supports (LTSS) providers, has interfaced with HHA Exchange for service providers in New Jersey.

Experts from Northern California-based cancer center to join panels responsible for evidence-based recommendations in NCCN Clinical Practice Guidelines and NCCN Guidelines for Patients, among other resources to improve outcomes for people with cancer.

Akoya Biosciences, Inc., The Spatial Biology Company ® , today announced its support for the Human Cell Atlas (HCA) initiative, offering the CODEX ® solution’s single-cell, whole-tissue imaging capabilities to HCA members under favorable commercial terms.